Laninamivir-d3 (CAS 203120-17-6 (unlabeled))

Laninamivir-d3 is a deuterated form of laninamivir, where three hydrogen atoms are replaced with deuterium. This isotopic labeling is used in scientific research to enhance the study of laninamivir′s dynamics and interactions within biological systems, particularly through improved analytical techniques like mass spectrometry and NMR spectroscopy. Laninamivir is a potent inhibitor of the influenza virus neuraminidase enzyme. This enzyme is crucial for the virus′s life cycle as it facilitates the release of new viral particles from infected host cells by cleaving the glycosidic linkages of neuraminic acids on the surface of host cells and viral glycoproteins. Laninamivir-d3, retaining this mechanism of action, binds to the active site of the neuraminidase enzyme. This binding prevents the enzyme from performing its natural function, effectively halting the spread of the virus by preventing the release of new viral particles from the surfaces of infected cells. In research, laninamivir-d3 is particularly valuable for its ability to provide clearer, more distinct signals in mass spectrometry and NMR spectroscopy, aiding in the precise measurement of the compound′s pharmacokinetics and distribution in biological tissues. This allows scientists to trace the absorption, distribution, metabolism, and excretion of laninamivir with high accuracy, providing deeper insights into how the molecule behaves under different physiological conditions. Additionally, laninamivir-d3 is used in studies focused on understanding the resistance mechanisms of influenza viruses. By comparing how different strains of the virus respond to both laninamivir and laninamivir-d3, researchers can identify mutations and other adaptive strategies the virus uses to evade antiviral agents. This research is crucial for developing next-generation inhibitors that can remain effective against resistant strains.